ディベート 5
3月27日［土］17:20-18:20
|
| |
| |
Antithrombotic therapy for secondary prevention of coronary artery disease-Merits and demerits of De-escalation-
|
|
|
| |
| |
|
|
| |
It has been established that high bleeding risk is associated with poor prognosis. In this context, a number of trials regarding DAPT(dual antiplatelet therapy) have been performed to reduce bleeding complications. In this debate session we discuss four issues, (1) clinical utility of platelet-function guide strategy, (2) de-escalation based on drug dose or change, (3) aspirin or P2Y12 inhibitor preferred as SAPT(single antiplatelet therapy) and (4) optimal DAPT duration. By presenting on this session we can learn recent knowledge contributing to better prognosis from the Italian and Japanese opinion leaders in this field.
|
|
|
| |
| |
|
|
| |
| |
 |
|
Kazuo Kimura
Division of Cardiology, Yokohama City University Medical Center, Yokohama
|
|
 |
|
Davide Francesco Capodanno
Cardiology Department, University of Catania, A.O.U. Policlinico, Italy
|
|
|
| |
| |
|
|
| |
| |
 |
|
Masato Nakamura
Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo
|
|
 |
|
Masaharu Ishihara
Department of Cardiovascular and Renal Medicine, Hyogo College of Medicine, Nishinomiya
|
|
|
| |
| |
 |
|
Hirotoshi Watanabe
Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto
|
|
 |
|
Fumiyuki Otsuka
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita
|
|
|
| |
| |
|
|